Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tns Inhibitors

Tns inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the Tns (tensin) protein family, which is involved in various cellular functions, particularly related to the actin cytoskeleton and cell-matrix adhesion. These inhibitors are designed to bind to critical regions of the Tns proteins, such as the active site or key functional domains, disrupting their normal biological activity. By occupying these important regions, Tns inhibitors block the interaction between Tns proteins and their natural binding partners, which may include cytoskeletal components or other signaling proteins. This inhibition affects the Tns proteins' role in organizing the cytoskeleton and influencing cell signaling pathways. In some cases, Tns inhibitors may also act allosterically by binding to non-active sites that induce conformational changes in the protein, leading to a reduction in its overall activity. These interactions are often stabilized by non-covalent forces, including hydrogen bonding, hydrophobic interactions, van der Waals forces, and electrostatic interactions, ensuring that the inhibitors effectively bind and modulate the activity of the Tns proteins.

Structurally, Tns inhibitors exhibit considerable diversity, with designs that range from small organic molecules to larger, more complex chemical frameworks. These inhibitors are often characterized by the presence of functional groups such as hydroxyl, carboxyl, or amine groups, which allow for specific interactions with amino acid residues in the Tns proteins' binding pockets. Many Tns inhibitors feature aromatic rings and heterocyclic structures that enhance hydrophobic interactions with non-polar regions of the protein. Additionally, the physicochemical properties of Tns inhibitors, including molecular weight, polarity, solubility, and lipophilicity, are carefully optimized to ensure that they can bind effectively and remain stable under various biological conditions. Hydrophobic regions within the inhibitors help them interact with non-polar areas of the Tns proteins, while polar or charged groups facilitate hydrogen bonding and electrostatic interactions with polar residues. This balance of hydrophilic and hydrophobic regions ensures that Tns inhibitors can effectively modulate the activity of the protein, achieving robust inhibition in different environments.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Novobiocin

303-81-1sc-362034
sc-362034A
5 mg
25 mg
$128.00
$380.00
(0)

A DNA gyrase inhibitor that changes DNA supercoiling and could affect transposase binding.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Forms DNA crosslinks that could hinder transposase access to DNA.

Aphidicolin

38966-21-1sc-201535
sc-201535A
sc-201535B
1 mg
5 mg
25 mg
$84.00
$306.00
$1104.00
30
(3)

Inhibits DNA polymerase and could alter the replication fork, potentially affecting transposable element insertion.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Interacts with DNA and inhibits RNA polymerase, which could impact transposase expression.

Quinomycin A

512-64-1sc-202306
1 mg
$166.00
4
(1)

A DNA intercalator that could sterically hinder transposase binding to DNA.

9-Aminoacridine free base

90-45-9sc-291761A
sc-291761
sc-291761B
sc-291761C
250 mg
1 g
5 g
10 g
$32.00
$80.00
$272.00
$501.00
(1)

Intercalates into DNA which may affect DNA conformation and transposase activity.

Ciprofloxacin

85721-33-1sc-217900
1 g
$43.00
8
(1)

A fluoroquinolone that inhibits DNA gyrase, potentially affecting DNA topology and transposase activity.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

DNA intercalator and topoisomerase II inhibitor which could interfere with transposase activity.